GAMMA Investing
ALXO icon

GAMMA Investing’s ALX Oncology ALXO Stock Holding History

GAMMA Investing’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$867 Buy
+624
New +$1.2K ﹤0.01% 4125
2024
Q3 		– Sell
-12
Closed -$72 – 3582
2024
Q2 		$72 Sell
12
-9
-43% -$111 ﹤0.01% 3414
2024
Q1 		$234 Buy
+21
New +$295 ﹤0.01% 3212

Other funds holding ALXO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
JSF Financial
JSF Financial Los Angeles, California $655M AUM 20.11% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

GAMMA Investing's ALXO Position: Q3 2026 in Review

GAMMA Investing opened a new position in ALX Oncology (ALXO) in Q3 2026: 624 shares worth $867. The stake represents ﹤0.01% of the portfolio and ranks #4125 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in ALXO as recently as Q2 2024.

GAMMA Investing first reported a position in ALXO in Q1 2024 and has held it in 3 quarters since. 26 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • GAMMA Investing held 624 shares of ALX Oncology worth $867 as of Q3 2026.
  • ALX Oncology was a new GAMMA Investing position in Q3 2026.
  • ALX Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4125 holding.
  • GAMMA Investing first reported a position in ALX Oncology in Q1 2024 and has held it in 3 quarters since.
  • 26 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.